{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:35:43Z","timestamp":1758040543925,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.amjmed.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T19:36:38Z","timestamp":1562182598000},"page":"1320-1326.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching"],"prefix":"10.1016","volume":"132","author":[{"given":"Ji Woong","family":"Roh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong-Hyeon","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moonjong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaewon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Young","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungha","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk-Jae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geu-Ru","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Won","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.amjmed.2019.06.003_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166246","article-title":"Statin intensity and clinical outcome in patients with stable coronary artery disease and very low LDL-cholesterol","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjmed.2019.06.003_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3349\/ymj.2017.58.1.82","article-title":"Assessment of coronary artery calcium scoring for statin treatment strategy according to ACC\/AHA guidelines in asymptomatic Korean adults","volume":"58","author":"Han","year":"2017","journal-title":"Yonsei Med J"},{"issue":"4","key":"10.1016\/j.amjmed.2019.06.003_bb0015","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4070\/kcj.2016.0406","article-title":"Combining potent statin therapy with other drugs to optimize simultaneous cardiovascular and metabolic benefits while minimizing adverse events","volume":"47","author":"Koh","year":"2017","journal-title":"Korean Circ J"},{"key":"10.1016\/j.amjmed.2019.06.003_bb0020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5551\/jat.46201","article-title":"Real-world data to identify hypercholesterolemia patients on suboptimal statin therapy","volume":"26","author":"Kajinami","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.amjmed.2019.06.003_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosissup.2017.05.013","article-title":"Management of patients with statin intolerance","volume":"30","author":"Fischer","year":"2017","journal-title":"Atheroscler Suppl"},{"issue":"7","key":"10.1016\/j.amjmed.2019.06.003_bb0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care settings: a cohort study","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2019.06.003_bb0035","article-title":"Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database","volume":"353","author":"Vinogradova","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amjmed.2019.06.003_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/clpt.2014.84","article-title":"A current approach to statin intolerance","volume":"96","author":"Tompkins","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl D","key":"10.1016\/j.amjmed.2019.06.003_bb0045","doi-asserted-by":"crossref","first-page":"D55","DOI":"10.1093\/eurheartj\/sux020","article-title":"ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance","volume":"19","author":"Gulizia","year":"2017","journal-title":"Eur Heart J Suppl"},{"issue":"5","key":"10.1016\/j.amjmed.2019.06.003_bb0050","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/jc.2009-2689","article-title":"Approach to the patient who is intolerant of statin therapy","volume":"95","author":"Eckel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjmed.2019.06.003_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2019.06.003_bb0060","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American Heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arteroscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.amjmed.2019.06.003_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/M16-0838","article-title":"Continued statin prescriptions after adverse reactions and patient outcomes: a cohort study","volume":"167","author":"Zhang","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.amjmed.2019.06.003_bb0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.amjcard.2017.06.015","article-title":"Comparison of low-dose statin versus low-dose statin+Armolipid Plus in high-intensity statin-intolerant patients with a previous coronary event and percutaneous coronary intervention (ADHERENCE Trial)","volume":"120","author":"Marazzi","year":"2017","journal-title":"Am J Cardiol"},{"issue":"10059","key":"10.1016\/j.amjmed.2019.06.003_bb0075","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjmed.2019.06.003_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2019.06.003_bb0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2007.09.099","article-title":"Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins","volume":"101","author":"Stein","year":"2008","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2019.06.003_bb0090","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.amjcard.2014.02.033","article-title":"Statin intolerance","volume":"113","author":"Ahmad","year":"2014","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.amjmed.2019.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"39","key":"10.1016\/j.amjmed.2019.06.003_bb0100","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2019.06.003_bb0105","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"43","key":"10.1016\/j.amjmed.2019.06.003_bb0110","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/eurheartj\/ehv393","article-title":"Lowering cholesterol in chronic kidney disease: is it safe and effective?","volume":"36","author":"Wong","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjmed.2019.06.003_bb0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease","volume":"45","author":"Baigent","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"9784","key":"10.1016\/j.amjmed.2019.06.003_bb0120","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.amjmed.2019.06.003_bb0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.archger.2008.12.012","article-title":"Statin therapy in the elderly: a review","volume":"50","author":"Szadkowska","year":"2010","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"10.1016\/j.amjmed.2019.06.003_bb0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pds.1287","article-title":"Risk factors for statin-associated rhabdomyolysis","volume":"16","author":"Schech","year":"2007","journal-title":"Pharmacoepidemilo Drug Saf"},{"issue":"20","key":"10.1016\/j.amjmed.2019.06.003_bb0135","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2019.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319305388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319305388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:19:03Z","timestamp":1757582343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319305388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0002934319305388"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.06.003","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}